Anxiety Disorders
1 competing product in clinical development for Anxiety Disorders.
Pipeline by Phase
Phase 31
All Products (1)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| Duloxetine + venlafaxine + placebo | Eli Lilly | Phase 3 | Completed | 77 |
1 competing product in clinical development for Anxiety Disorders.
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| Duloxetine + venlafaxine + placebo | Eli Lilly | Phase 3 | Completed | 77 |